U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5996127

Wearable Device For Feeding and Observing Birds and Other Flying Animals

A device for feeding and observing flying animals comprising a hat, a support mounted on the hat and extending outward from the hat, and a feeder mounted on the support.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 560/159 - Additional nitrogen in acid moiety


Subclass of Class 560 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the acid radical contains covalently bonded
No. of applications: 40
Last issue date: 02/23/2012


Application No.Application TitleIssue Date
20120046272Novel Therapeutic Compounds
The present invention describes a series of therapeutically active compounds of formula I,


X—Y—Z  (I)

that are useful for treating a disorder in a mammal. In the f...

02/23/2012
20120016073METHOD FOR PREPARING AN ALLOPHANATE, ALLOPHANATE, AND LOW-VISCOSITY COMPOSITION CONTAINING THE ALLOPHANATE
A process for the preparation of an allophanate of one or more identical or different isocyanates, compositions obtained by the process, and uses of the compositions are disclosed. The process comprises reacting an isocyanate with at least one monoalcohol comprising an ...
01/19/2012
20120010415PROCESS FOR THE PREPARATION OF 6-(7-((1-AMINOCYCLOPROPYL)METHOXY)-6-METHOXYQUINOLIN-4-YLOXY)-N-METHYL-1-NAPHTHAMIDE AND SYNTHETIC INTERMEDIATES THEREOF
A process for the preparation in high yields and purity of the compound 6-(7-4(1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide of formula (I) and of the pharmaceutically acceptable salts thereof is described. The process has various advanta...
01/12/2012
20110312007Detection of Histone Deacetylase Inhibition
Provided are compositions and methods for intracellular detection of enzyme activity. One example of a composition is a histone deacetylase substrate comprising a compound of the following formula (I):

One ex...

12/22/2011
20110306600NOVEL THERAPEUTIC COMPOUNDS
The invention discloses a number of therapeutic compounds and a method of treating a disorder in mammal....
12/15/2011
20110294878Inhibitors of Dimethylarginine Dimethylaminohydrolase
The invention relates to an inhibitor of dimethylarginine dimethylaminohydrolase (DDAH) of general structural formula (I), wherein B is a branched or unbranched, substituted or non-substituted, saturated or unsaturated hydrocarbon chain having a chain length of 1 to 6 a...
12/01/2011
20110275590CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS
The present invention relates to conjugates of a drug and an amino acid or an amino acid derivative or analog, pharmaceutical compositions that include the conjugates and methods of use thereof. In particular, the present invention relates to conjugates of anti-prolifer...
11/10/2011
20110251338MICHAEL ACCEPTOR HAVING MULTIPLE HYDROXYL GROUPS, AND MICHAEL ADDITION PRODUCT DERIVED THEREFROM
Provided is a Michael addition product prepared from a multifunctional acryl monomer having multiple hydroxyl groups allowing introduction of acryl functional groups, as a Michael acceptor, and a Michael donor. The Michael addition product is a novel multifunctional com...
10/13/2011
20110230666 PROCESS FOR THE SEPARATION OF ENANTIOMERICALLY PURE COMPOUNDS
The present patent application relates to an improved process for the separation of enantiomerically pure compounds. Specifically it relates to separation of enantiomerically enriched Rivastigmine, Duloxetine, Escitalopram and their intermediates in high yields....
09/22/2011
20110178291Process for the manufacture of bridged monobactam intermediates
A process for manufacturing a compound of Formula (I) which has cis-conformation and wherein R1 represents a 1-phenyl-C1-C4alkyl or 1-naphthyl-C1-C4alkyl group, wherein the phenyl or naphthyl moiety of R1 is unsubstituted or s...
07/21/2011
20110165037INTERFACES THAT ELIMINATE NON-SPECIFIC ADSORPTION, AND INTRODUCE SPECIFIC INTERACTIONS
A microfluidic system comprising a microchannel, a carrier fluid comprising a fluorinated oil in the microchannel, at least one plug comprising an aqueous plug-fluid in the microchannel and substantially surrounded on all sides by the carrier-fluid, and a fluorinated su...
07/07/2011
20110144201METHOD FOR IMPROVING THE TOLERANCE OF CROPS TO CHILLING TEMPERATURES AND/OR FROST
The present invention relates to the use of propamocarb and derivatives thereof for improving the tolerance of crops to chilling temperatures and/or frost....
06/16/2011
20110133121N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound
The present invention is a method for producing an N-substituted carbamic acid ester derived from an organic amine from an organic amine, a carbonic acid derivative and a hydroxy composition containing one or more types of hydroxy compounds, wherein the organic amine, t...
06/09/2011
20110082090COMPOUNDS SUITED AS NANOCARRIERS FOR ACTIVE AGENTS AND THEIR USE
The invention relates to a compound suited as entity carrier, having the general formula (I)

wherein X is an amine-containing residue further defined herein. The invention further relates to the use of such c...

04/07/2011
20110053848PRODRUG COMPRISING A DRUG LINKER CONJUGATE
The present invention relates to a prodrug or a pharmaceutically acceptable salt thereof comprising a drug linker conjugate D-L, wherein -D is an amine containing biologically active moiety; and -L is a non-biologically active linker moiety -L1 represented by...
03/03/2011
20100324264SYNTHESIS OF A PEG-6 MOIETY FROM COMMERCIAL LOW-COST CHEMICALS
The present invention provides novel synthesis's for obtaining a protecting group aminoxy PEG-6 linker from cost effective, and readily available starting materials and chemicals or modified polyethylene glycols. More specifically, a novel synthesis of obtaining a modif...
12/23/2010
20100319580MODIFIED GLYCIDYL CARBAMATE RESINS
The invention relates to alcohol-modified glycidyl carbamate resins wherein at least some of the glycidol groups in the resin have been replaced with an alcohol. The invention also relates to coating compositions containing the resins....
12/23/2010
20100310540METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIA ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS
Provided are methods of screening compounds for any aspirin-related activity other than TAFI inhibition, and also for non-inhibition of TAFI. Compounds identified by the screening methods can be used to treat, prevent or manage in a patient pain, fever, colon cancer, pa...
12/09/2010
20100305333LIPID CONJUGATED CYCLIC CARBONATE DERIVATIVES, THEIR SYNTHESIS, AND USES
The present disclosure provides processes for the preparation of lipid conjugated cyclic carbonate derivatives. More specifically, the present disclosure is based on the finding that reacting lipids, such as, ceramides, with N,N′-disuccinimidyl derivative, resulted in...
12/02/2010
20100278750POLYLYSINE DENDRIMER CONTRAST AGENT
The present invention relates generally to branched macromolecules and their use as imaging or contrast agents. In particular, the invention relates to dendrimers, derived from lysine or lysine analogues, bearing a plurality of functional moieties and their application ...
11/04/2010
20100204434Process For The Preparation Of Particularly Reactive And Low-Viscosity Allophanates Having Actinic-Curable Groups And The Use Thereof For The Preparation Of Particularly Scratch-Resistant Coatings
The present invention relates to a process for the preparation of particularly reactive and low-viscosity reaction products of polyisocyanates which contain activated ethylenically unsaturated groups which react by polymerization under the action of actinic radiation, a...
08/12/2010
20100190688Tetrapeptide analogs
Compounds, compositions and methods for treatment of hyperproliferative diseases, such as cancer are provided....
07/29/2010
20100137600Photogenerated reagents
This invention describes reagent precursors and methods for chemical and biochemical reactions. These reagent precursors that can be activated in solution upon irradiation to generate reagents required for the subsequent chemical reactions. Specifically, photogenerated ...
06/03/2010
20100062465Detection of Histone Deacetylase Inhibition
Provided are compositions and methods for intracellular detection of enzyme activity. One example of a composition is a histone deacetylase substrate comprising a compound of the following formula (I): One example of a method is a method for detecting histone deacetylas...
03/11/2010
20100035930UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa
The invention relates to compounds of the formula I

as defined herein, which are inhibitors of activated thrombin-activatable fibrinolysis inhibitor. The compounds of the formula I are suitable for manufactur...

02/11/2010
20080200719Acid and base stable diphenylmethanol derivatives and methods of use
The invention provides compounds that are useful as linkers for solid phase synthesis and as protecting groups, and methods for producing and using the same....
08/21/2008
200801883714-Biphenyl-Substituted Pyrazolidin-3,5-Dione Derivatives
The present invention relates to novel 4-biphenyl-substituted pyrazolidine-3,5-dione derivatives of the formula (I)

in which

A, D, G, W, X, Y and Z are as defined above,

08/07/2008
20080153899FATTY AMINE DRUG CONJUGATES
The invention provides conjugates of fatty amines and pharmaceutical agents useful in treating cancer, viruses, psychiatric disorders. Compositions, pharmaceutical preparations, and methods of preparations of the fatty amine-pharmaceutical agent conjugates are provided....
06/26/2008
20080125350BRANCHED POLYALKYLENE GLYCOLS
The present invention provides a branched polyalkylene glycol wherein three or more single-chain polyalkylene glycols and a group having reactivity with an amino acid side chain, the N-terminal amino group or the C-terminal carboxyl group in a polypeptide or a group con...
05/29/2008
20080095704Imaging Agents with Improved Pharmacokinetic Profiles
The invention relates to compounds suitable for use in an imaging agent said imaging agent showing an improved pharmacokinetic profile....
04/24/2008
20080058546Methods for Synthesis of Acyloxyalkyl Derivatives of GABA Analogs
The synthesis of 1-(acyloxy)-alkyl carbamates of GABA analogs from 1-haloalkyl carbamates of GABA analogs are described. Also described are new 1-haloalkyl carbamates of GABA analogs. ...
03/06/2008
20070197821Process for the preparation of high purity perindopril
The invention relates to 1-{2(S)-[1(S)-(ethoxycarbonyl)butylamino]propionyl}-(3aS,7aS)octahydroindol-2(S)-carboxylic acid of the Formula I and the t-butylamine salt of the Formula I′ thereof free of contaminations derivable from dicyclohexyl carbodiimide, and a proces...
08/23/2007
20070173149WATER- AND OIL-REPELLENT FLUOROACRYLATES
Fluoroacrylates comprise the reaction product of: (a) at least one fluorochemical alcohol represented by the formula:
CnF2n+1—X—OH wherein:
n=1 to 4, R=hydrogen or an alkyl group of 1 to 4 carbon...
07/26/2007
20070167606Polyethylene glycol aldehydes
Polyethylene glycol aldehyde compounds are provided. Methods of making and using such compounds, as well as chemical intermediates are also provided. ...
07/19/2007
20070092476Compounds and use to reduce the formation of malodour
Malodour formation reducing compounds alpha-N-(3-Methyl-5-phenylpentanoxycarbonyl)-L-glutamine, alpha-N-(2-Methyl-5-phenylpentanoxycarbonyl)-L-glutamine, and alpha-N-(2,4-Dimethyl-4-phenylbutanoxycarbonyl)-L-glutamine, and their salts, compositions comprising such compo...
04/26/2007
20070049635Diamine derivatives, process for producing the same, and plant disease control agents containing the same as active ingredients
It is an object of the present invention to provide a diamine derivative, a process for producing the same, and a plant disease control agent containing the above-described compound as an active ingredient.
According to the present invention, a diamine derivative...
03/01/2007
20060258740Diacylglycerol acyltransferase inhibitors
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the tre...
11/16/2006
20060247291Amino acid derivatives
The present invention relates to a method of treating pain using a compound of formula
wherein R1, R2, R3 and R4 are as defined herein. The invention also relates to certain novel derivatives of formula (I). ...
11/02/2006
20050197290Releasable polymeric conjugates based on biodegradable linkers
Activated polymeric bicine derivatives such as, as well as conjugates made therewith are disclosed. Methods of making and using the bicine derivatives are also disclosed. ...
09/08/2005
20050101763Synthesis of photolabile 2-(2-nitrophenyl)propyloxycarbonyl protected amino acids
The 2-(2-nitrophenyl)propyloxycarbonyl (NPPOC) group has been introduced as a photolabile amino protecting group for amino acids to be used as building blocks in photolithographic solid-phase peptide synthesis. NPPOC-protected amino acids were found to be cleaved in the...
05/12/2005
 
Sign InRegister
Username  
Password   
forgot password?